Gaining Weight on Mounjaro: What It Means and What to Do Next

Is it really weight gain, or is the scale lying to you?

This is the first decision worth making: are you seeing true fat gain, or is the number on the scales misleading you? Several things can push the scale up that have nothing to do with gaining body fat. Water retention is common during dose changes, particularly in the first week or two at a new strength. Hormonal shifts across the menstrual cycle routinely add one to three kilograms of fluid weight that resolves on its own. Starting a strength-training programme alongside Mounjaro, which many prescribers actively encourage, can increase lean muscle mass and send the number on the scale upward even as your waist measurement falls.

The tirzepatide trials measured body weight, but the most meaningful measure is body composition. The relationship between Mounjaro and weight training is worth understanding here: muscle weighs more than the same volume of fat, so a scale reading can go up while your health genuinely improves. Before concluding that tirzepatide is not working, track measurements alongside weight, and note how your clothes fit. A single weigh-in after a heavy meal or late in the day tells you very little.

That said, if the upward movement persists across four or more weeks, measured consistently and at the same time each morning, something more specific is probably at play.

Why some people gain weight on tirzepatide: the real causes

Mounjaro is a dual GIP and GLP-1 receptor agonist, meaning it works on two gut-hormone pathways to reduce appetite and slow how quickly the stomach empties. The appetite-suppressing effect tends to be strongest at higher doses. At the starting dose of 2.5 mg, the medicine is primarily settling your system rather than delivering its full effect, so some people eat roughly the same amount as before and see little change. If calorie intake is not meaningfully lower, weight can remain flat or nudge upward.

Underdosing is another factor that comes up more than people expect. If a pen has been stored incorrectly, used past its in-use window, or administered with a blunt needle, less medicine may be delivered than intended. Keep your pen in the fridge door until you're ready to use it, and always follow the instructions in the Patient Information Leaflet for storage and injection technique.

Certain medications taken alongside Mounjaro can promote weight gain independently: some antidepressants, corticosteroids, antipsychotics and insulin regimens are well-known examples. If a new medicine was added around the time the weight started rising, that is worth flagging to your prescriber. Underlying thyroid conditions, polycystic ovary syndrome and other hormonal factors can also work against the medicine's effect. There are factors specific to female physiology that are worth reading about separately if that applies to you.

The tirzepatide overview at nume (sorry) on the tirzepatide page sets out how the medicine works in full, which helps frame why these individual variables matter so much.

What the clinical evidence tells us about weight gain in trials

In SURMOUNT-1, the large phase-3 trial published in the New England Journal of Medicine, the majority of participants on tirzepatide lost significant amounts of weight over 72 weeks, with average reductions of around 15–21% depending on dose. A minority, however, did not respond as strongly, and a small number saw weight increase. The trial excluded people with a range of confounding conditions, which means real-world outcomes are more variable than headline trial figures suggest.

NICE's appraisal of tirzepatide, published as TA1026, notes that patients who have not lost at least 5% of their body weight after six months at the highest tolerated dose should have their treatment reviewed. That review is a clinical conversation, not an automatic instruction to stop. There may be modifiable reasons for the poor response that are worth addressing first.

If you want to understand more about the patterns behind inadequate response, a closer look at weight gain on Mounjaro and what drives it cover the topic in more depth.

What to actually do if you're gaining weight on Mounjaro

The starting point is a conversation with your prescriber, not a decision made on your own. Stopping tirzepatide abruptly because the scale moved in the wrong direction one week is rarely the right call, and there is good evidence that weight returns quickly after stopping GLP-1 medicines without a proper plan. Stopping or tapering the medicine, if that is ultimately the right decision, should happen with clinical support.

The NHS tirzepatide medicines page is a reliable first reference for understanding what the medicine is and is not doing, and it is worth reading before your review appointment so you can ask specific questions.

At nume, every repeat order is reviewed by a GPhC-registered prescriber before anything is dispatched. If something has changed in your response to treatment, that review is the moment to raise it. You can also reach the aftercare team seven days a week. If you have questions about whether your situation is a good fit for tirzepatide in the first place, or want to understand the broader range of weight-loss options, a free consultation is a sensible place to start.

Cost is sometimes a reason people delay that conversation. For context on what private treatment involves financially, the Mounjaro price guide sets out what to expect and what to look for. Check your eligibility and speak to a prescriber who can actually look at your situation.